Cancer Research and Treatment

Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic Neurotoxicity

Ambika Menon, Chidiebele A. Enunwa, William L. Read, Kyle P. James

Case Reports in Oncology.2024; 17(1): 202. CrossRef

Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy

Ragini D. Singh, Avadhesh Avadhesh, Gaurav Sharma, Sagar Dholariya, Rima B. Shah, Bela Goyal, Subash Chandra Gupta

Antioxidants & Redox Signaling.2023; 38(10-12): 853. CrossRef

Ifosfamide - History, efficacy, toxicity and encephalopathy

Pharmacology & Therapeutics.2023; 243: 108366. CrossRef

A Case of Encephalopathy Caused by Drug Interaction between Ifosfamide and Aprepitant

Tomomi Sano, Nokitaka Setsu, Eisuke Kobayashi, Akira Kawai

Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies

Ali Zarrabi, David Perrin, Mahboubeh Kavoosi, Micah Sommer, Serap Sezen, Parvaneh Mehrbod, Bhavya Bhushan, Filip Machaj, Jakub Rosik, Philip Kawalec, Saba Afifi, Seyed Mohammadreza Bolandi, Peiman Koleini, Mohsen Taheri, Tayyebeh Madrakian, Marek J. Łos,

Ifosfamide-induced Encephalopathy With Rapid Response to Thiamine: A Pediatric Case

Eren Müngen, İnci Yaman Bajin, Sibel Öz, Ceren Günbey, Banu Anlar, Burca Aydin

Journal of Pediatric Hematology/Oncology.2022; 44(7): 402. CrossRef

Methylene blue and ifosfamide-induced encephalopathy: Myth or reality?

Halima Abahssain, Badreddine Moukafih, Hajar Essangri, Hind Mrabti, Bouchra Meddah, Fadila Guessous, Fatima Zahra Fadhil, Amine Souadka, Hassan Errihani

Journal of Oncology Pharmacy Practice.2021; 27(1): 143. CrossRef

Effect of Berberis vulgaris L. root extract on ifosfamide-induced in vivo toxicity and in vitro cytotoxicity

Shazia Ilyas, Raheela Tabasum, Ali Iftikhar, Mamoona Nazir, Amina Hussain, Aroosha Hussain, Muhammad Sajjad Ali, Farooq Saleem, Uzma Saleem, Matheus Froeyen, Iskandar Abdullah, Muhammad Usman Mirza, Sarfraz Ahmad

Ifosfamide-related encephalopathy with severe clinical presentations in children with cancer

Eda Ataseven, Şebnem Önen Göktepe, Mehmet Kantar

Journal of Oncology Pharmacy Practice.2021; 27(8): 2018. CrossRef

Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies

Advances in Medical Sciences.2020; 65(2): 265. CrossRef

American Journal of Therapeutics.2020; 27(6): e613. CrossRef

Clinical and EEG Characteristics of Ifosfamide-Related Encephalopathy

Journal of Clinical Neurophysiology.2019; 36(2): 150. CrossRef

Incidence et facteurs de risque de l’encéphalopathie à l’ifosfamide chez les patients suivis pour un sarcome

Natacha Stern, Ilyes Sakji, Anne-Sophie Defachelles, Cyril Lervat, Thomas Ryckewaert, Guillaume Marliot, Charlotte Peugniez, Dominique Deplanque, Nicolas Penel

Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis

Yin Lo, Li-Jiuan Shen, Wen-Hwei Chen, Yaa-Hui Dong, Fe-Lin Lin Wu

Journal of the Formosan Medical Association.2016; 115(9): 744. CrossRef

The Neurotoxicity and Pharmacokinetics of Oral Ifosfamide

Martin S. Highley, Guido Momerency, Diane Sawyers, Ernst A. De Bruijn, Hans Prenen, Gunther Guetens, Gert De Boeck, Allan T. Van Oosterom, Janine L. Mansi, Peter R. Blake, Tim Mant, Robert A.A. Maes , Peter G. Harper

Journal of Analytical Oncology.2015;[Epub] CrossRef

Ifosfamide related encephalopathy: The need for a timely EEG evaluation

Journal of the Neurological Sciences.2014; 336(1-2): 109. CrossRef

Daniella Lowenberg, Caroline F. Thorn, Zeruesenay Desta, David A. Flockhart, Russ B. Altman, Teri E. Klein

Pharmacogenetics and Genomics.2014; 24(2): 133. CrossRef

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant

Alice Séjourné, Sabine Noal, Mathieu Boone, Céline Bihan, Marion Sassier, Michel Andrejak, Bruno Chauffert

Case Reports in Oncology.2014; 7(3): 669. CrossRef